1. Barde, Y.A.; Edgar, D.; Thoenen, H. Purification of a new neurotrophic factor from mammalian brain. EMBO J. 1982, 1, 549–553. [CrossRef] [PubMed]
2. Leibrock, J.; Lottspeich, F.; Hohn, A.; Hofer, M.; Hengerer, B.; Masiakowski, P.; Thoenen, H.; Barde, Y.A. Molecular cloning and expression of brain-derived neurotrophic factor. Nature 1989, 341, 149–152. [CrossRef] [PubMed]
3. Bibel, M.; Barde, Y.A. Neurotrophins: Key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev. 2000, 14, 2919–2937. [CrossRef] [PubMed]
4. Lessmann, V.; Brigadski, T. Mechanisms, locations, and kinetics of synaptic BDNF secretion: An update. Neurosci. Res. 2009, 65, 11–22. [CrossRef]
5. Aid, T.; Kazantseva, A.; Piirsoo, M.; Palm, K.; Timmusk, T. Mouse and rat BDNF gene structure and expression revisited. J. Neurosci. Res. 2007, 85, 525–535. [CrossRef]
6. Park, H.; Poo, M.M. Neurotrophin regulation of neural circuit development and function. Nat. Rev. Neurosci. 2013, 14, 7–23.
7. Egan, M.F.; Kojima, M.; Callicott, J.H.; Goldberg, T.E.; Kolachana, B.S.; Bertolino, A.; Zaitsev, E.; Gold, B.; Goldman, D.; Dean, M.; et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112, 257–269. [CrossRef]
8. Castren, E.; Rantamaki, T. The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Dev. Neurobiol. 2010, 70, 289–297. [CrossRef]
9. Autry, A.E.; Monteggia, L.M. Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol. Rev. 2012, 64, 238–258. [CrossRef]
10. Bjorkholm, C.; Monteggia, L.M. BDNF—A key transducer of antidepressant effects. Neuropharmacology 2016, 102, 72–79. [CrossRef]
11. Dunham, J.S.; Deakin, J.F.; Miyajima, F.; Payton, A.; Toro, C.T. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains. J. Psychiatr. Res. 2009, 43, 1175–1184. [CrossRef] [PubMed]
12. Thompson Ray, M.; Weickert, C.S.; Wyatt, E.; Webster, M.J. Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. J. Psychiatry Neurosci. JPN 2011, 36, 195–203. [CrossRef] [PubMed]
13. Guilloux, J.P.; Douillard-Guilloux, G.; Kota, R.; Wang, X.; Gardier, A.M.; Martinowich, K.; Tseng, G.C.; Lewis, D.A.; Sibille, E. Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression. Mol. Psychiatry 2012, 17, 1130–1142. [CrossRef]
14. Tripp, A.; Oh, H.; Guilloux, J.P.; Martinowich, K.; Lewis, D.A.; Sibille, E. Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder. Am. J. Psychiatry 2012, 169, 1194–1202. [CrossRef]
15. Dwivedi, Y.; Rizavi, H.S.; Zhang, H.; Mondal, A.C.; Roberts, R.C.; Conley, R.R.; Pandey, G.N. Neurotrophin receptor activation and expression in human postmortem brain: Effect of suicide. Biol. Psychiatry 2009, 65, 319–328. [CrossRef]
16. Monteggia, L.M.; Luikart, B.; Barrot, M.; Theobold, D.; Malkovska, I.; Nef, S.; Parada, L.F.; Nestler, E.J. Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol. Psychiatry 2007, 61, 187–197. [CrossRef]
17. Taliaz, D.; Stall, N.; Dar, D.E.; Zangen, A. Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis. Mol. Psychiatry 2010, 15, 80–92. [CrossRef]
18. Saarelainen, T.; Hendolin, P.; Lucas, G.; Koponen, E.; Sairanen, M.; MacDonald, E.; Agerman, K.; Haapasalo, A.; Nawa, H.; Aloyz, R.; et al. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J. Neurosci. Off. J. Soc. Neurosci. 2003, 23, 349–357. [CrossRef]
19. Li, Y.; Luikart, B.W.; Birnbaum, S.; Chen, J.; Kwon, C.H.; Kernie, S.G.; Bassel-Duby, R.; Parada, L.F. TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment. Neuron 2008, 59, 399–412. [CrossRef]
20. MacQueen, G.M.; Ramakrishnan, K.; Croll, S.D.; Siuciak, J.A.; Yu, G.; Young, L.T.; Fahnestock, M. Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression. Behav. Neurosci. 2001, 115, 1145–1153. [CrossRef]
21. Lindholm, J.S.; Castren, E. Mice with altered BDNF signaling as models for mood disorders and antidepressant effects. Front. Behav. Neurosci. 2014, 8, 143. [CrossRef] [PubMed]
22. Smith, M.A.; Makino, S.; Kvetnansky, R.; Post, R.M. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J. Neurosci. Off. J. Soc. Neurosci. 1995, 15, 1768–1777. [CrossRef]
23. Duman, R.S.; Monteggia, L.M. A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 2006, 59, 1116–1127. [CrossRef]
24. Molteni, R.; Calabrese, F.; Cattaneo, A.; Mancini, M.; Gennarelli, M.; Racagni, G.; Riva, M.A. Acute stress responsiveness of the neurotrophin BDNF in the rat hippocampus is modulated by chronic treatment with the antidepressant duloxetine. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 2009, 34, 1523–1532. [CrossRef] [PubMed]
25. Mishima, Y.; Shinoda, Y.; Sadakata, T.; Kojima, M.; Wakana, S.; Furuichi, T. Lack of stress responses to long-term effects of corticosterone in Caps2 knockout mice. Sci. Rep. 2015, 5, 8932. [CrossRef]
26. Krishnan, V.; Nestler, E.J. The molecular neurobiology of depression. Nature 2008, 455, 894–902. [CrossRef]
27. Teng, H.K.; Teng, K.K.; Lee, R.; Wright, S.; Tevar, S.; Almeida, R.D.; Kermani, P.; Torkin, R.; Chen, Z.Y.; Lee, F.S.; et al. ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J. Neurosci. Off. J. Soc. Neurosci. 2005, 25, 5455–5463. [CrossRef]
28. Woo, N.H.; Teng, H.K.; Siao, C.J.; Chiaruttini, C.; Pang, P.T.; Milner, T.A.; Hempstead, B.L.; Lu, B. Activation of p75NTR by proBDNF facilitates hippocampal long-term depression. Nat. Neurosci. 2005, 8, 1069–1077. [CrossRef]
29. Koshimizu, H.; Kiyosue, K.; Hara, T.; Hazama, S.; Suzuki, S.; Uegaki, K.; Nagappan, G.; Zaitsev, E.; Hirokawa, T.; Tatsu, Y.; et al. Multiple functions of precursor BDNF to CNS neurons: Negative regulation of neurite growth, spine formation and cell survival. Mol. Brain 2009, 2, 27. [CrossRef]
30. Inoue, N.; Ikawa, M.; Isotani, A.; Okabe, M. The immunoglobulin superfamily protein Izumo is required for sperm to fuse with eggs. Nature 2005, 434, 234–238. [CrossRef]
31. Nawa, H.; Carnahan, J.; Gall, C. BDNF protein measured by a novel enzyme immunoassay in normal brain and after seizure: Partial disagreement with mRNA levels. Eur. J. Neurosci. 1995, 7, 1527–1535. [CrossRef] [PubMed]
32. Rauskolb, S.; Zagrebelsky, M.; Dreznjak, A.; Deogracias, R.; Matsumoto, T.; Wiese, S.; Erne, B.; Sendtner, M.; Schaeren-Wiemers, N.; Korte, M.; et al. Global deprivation of brain-derived neurotrophic factor in the CNS reveals an area-specific requirement for dendritic growth. J. Neurosci. Off. J. Soc. Neurosci. 2010, 30, 1739–1749. [CrossRef] [PubMed]
33. Lessmann, V.; Gottmann, K.; Malcangio, M. Neurotrophin secretion: Current facts and future prospects. Prog. Neurobiol. 2003, 69, 341–374. [CrossRef]
34. Wosnitzka, E.; Nan, X.; Nan, J.; Chacon-Fernandez, P.; Kussmaul, L.; Schuler, M.; Hengerer, B.; Barde, Y.A. A New Mouse Line Reporting the Translation of Brain-Derived Neurotrophic Factor Using Green Fluorescent Protein. eNeuro 2020, 7. [CrossRef]
35. Donovan, M.J.; Lin, M.I.; Wiegn, P.; Ringstedt, T.; Kraemer, R.; Hahn, R.; Wang, S.; Ibanez, C.F.; Rafii, S.; Hempstead, B.L. Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development 2000, 127, 4531–4540.
36. Wallace, D.L.; Han, M.H.; Graham, D.L.; Green, T.A.; Vialou, V.; Iniguez, S.D.; Cao, J.L.; Kirk, A.; Chakravarty, S.; Kumar, A.; et al. CREB regulation of nucleus accumbens excitability mediates social isolation-induced behavioral deficits. Nat. Neurosci. 2009, 12, 200–209. [CrossRef]
37. Crowley, J.J.; Blendy, J.A.; Lucki, I. Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test. Psychopharmacology 2005, 183, 257–264. [CrossRef]
38. Deacon, R.M. Assessing nest building in mice. Nat. Protoc. 2006, 1, 1117–1119. [CrossRef]
39. Deacon, R. Assessing burrowing, nest construction, and hoarding in mice. J. Vis. Exp. 2012, e2607. [CrossRef]
40. Castren, E.; Kojima, M. Brain-derived neurotrophic factor in mood disorders and antidepressant treatments. Neurobiol. Dis. 2017, 97, 119–126. [CrossRef]
41. Yang, J.; Harte-Hargrove, L.C.; Siao, C.J.; Marinic, T.; Clarke, R.; Ma, Q.; Jing, D.; Lafrancois, J.J.; Bath, K.G.; Mark, W.; et al. proBDNF negatively regulates neuronal remodeling, synaptic transmission, and synaptic plasticity in hippocampus. Cell Rep. 2014, 7, 796–806. [CrossRef] [PubMed]
42. Matsumoto, T.; Rauskolb, S.; Polack, M.; Klose, J.; Kolbeck, R.; Korte, M.; Barde, Y.A. Biosynthesis and processing of endogenous BDNF: CNS neurons store and secrete BDNF, not pro-BDNF. Nat. Neurosci. 2008, 11, 131–133. [CrossRef] [PubMed]
43. Qiao, H.; An, S.C.; Xu, C.; Ma, X.M. Role of proBDNF and BDNF in dendritic spine plasticity and depressive-like behaviors induced by an animal model of depression. Brain Res. 2017, 1663, 29–37. [CrossRef] [PubMed]
44. Zhong, F.; Liu, L.; Wei, J.L.; Hu, Z.L.; Li, L.; Wang, S.; Xu, J.M.; Zhou, X.F.; Li, C.Q.; Yang, Z.Y.; et al. Brain-Derived Neurotrophic Factor Precursor in the Hippocampus Regulates Both Depressive and Anxiety-Like Behaviors in Rats. Front. Psychiatry 2018, 9, 776. [CrossRef]
45. Zhao, G.; Zhang, C.; Chen, J.; Su, Y.; Zhou, R.; Wang, F.; Xia, W.; Huang, J.; Wang, Z.; Hu, Y.; et al. Ratio of mBDNF to proBDNF for Differential Diagnosis of Major Depressive Disorder and Bipolar Depression. Mol. Neurobiol. 2017, 54, 5573–5582. [CrossRef]
46. McEwen, B.S.; Bowles, N.P.; Gray, J.D.; Hill, M.N.; Hunter, R.G.; Karatsoreos, I.N.; Nasca, C. Mechanisms of stress in the brain. Nat. Neurosci. 2015, 18, 1353–1363. [CrossRef]
47. Nestler, E.J.; Barrot, M.; DiLeone, R.J.; Eisch, A.J.; Gold, S.J.; Monteggia, L.M. Neurobiology of depression. Neuron 2002, 34, 13–25. [CrossRef]
48. Martinowich, K.; Manji, H.; Lu, B. New insights into BDNF function in depression and anxiety. Nat. Neurosci. 2007, 10, 1089–1093. [CrossRef]
49. Hajszan, T.; Dow, A.; Warner-Schmidt, J.L.; Szigeti-Buck, K.; Sallam, N.L.; Parducz, A.; Leranth, C.; Duman, R.S. Remodeling of hippocampal spine synapses in the rat learned helplessness model of depression. Biol. Psychiatry 2009, 65, 392–400. [CrossRef]
50. Xu, B.; Xie, X. Neurotrophic factor control of satiety and body weight. Nat. Rev. Neurosci. 2016, 17, 282–292. [CrossRef]
51. Cao, L.; Choi, E.Y.; Liu, X.; Martin, A.; Wang, C.; Xu, X.; During, M.J. White to brown fat phenotypic switch induced by genetic and environmental activation of a hypothalamic-adipocyte axis. Cell Metab. 2011, 14, 324–338. [CrossRef] [PubMed]
52. Heller, H.C.; Salehi, A.; Chuluun, B.; Das, D.; Lin, B.; Moghadam, S.; Garner, C.C.; Colas, D. Nest building is impaired in the Ts65Dn mouse model of Down syndrome and rescued by blocking 5HT2a receptors. Neurobiol. Learn. Mem. 2014, 116, 162–171. [CrossRef] [PubMed]
53. Van de Weerd, H.A.; Van Loo, P.L.; Van Zutphen, L.F.; Koolhaas, J.M.; Baumans, V. Preferences for nesting material as environmental enrichment for laboratory mice. Lab. Anim. 1997, 31, 133–143. [CrossRef] [PubMed]
54. Kolb, B. Functions of the frontal cortex of the rat: A comparative review. Brain Res. 1984, 320, 65–98. [CrossRef]
55. Carter, P.A.; Swallow, J.G.; Davis, S.J.; Garland, T., Jr. Nesting behavior of house mice (Mus domesticus) selected for increased wheel-running activity. Behav. Genet. 2000, 30, 85–94. [CrossRef] [PubMed]
56. Deacon, R.M.; Croucher, A.; Rawlins, J.N. Hippocampal cytotoxic lesion effects on species-typical behaviours in mice. Behav. Brain Res. 2002, 132, 203–213. [CrossRef]
57. Deacon, R.M.; Penny, C.; Rawlins, J.N. Effects of medial prefrontal cortex cytotoxic lesions in mice. Behav. Brain Res. 2003, 139, 139–155. [CrossRef]
58. Filali, M.; Lalonde, R. Age-related cognitive decline and nesting behavior in an APPswe/PS1 bigenic model of Alzheimer’s disease. Brain Res. 2009, 1292, 93–99. [CrossRef]
59. Otabi, H.; Goto, T.; Okayama, T.; Kohari, D.; Toyoda, A. Subchronic and mild social defeat stress alter mouse nest building behavior. Behav. Process. 2016, 122, 21–25. [CrossRef]
60. Otabi, H.; Goto, T.; Okayama, T.; Kohari, D.; Toyoda, A. The acute social defeat stress and nest-building test paradigm: A potential new method to screen drugs for depressive-like symptoms. Behav. Process. 2017, 135, 71–75. [CrossRef]
61. Vaidya, V.A.; Marek, G.J.; Aghajanian, G.K.; Duman, R.S. 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J. Neurosci. Off. J. Soc. Neurosci. 1997, 17, 2785–2795. [CrossRef]
62. Shelton, R.C.; Sanders-Bush, E.; Manier, D.H.; Lewis, D.A. Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A. Neuroscience 2009, 158, 1406–1415. [CrossRef] [PubMed]
論文の公開元へ
